SURG SURGEPAYS INC revenue, earnings and financials
For the quarter ended June 30, 2026, SURGEPAYS INC reported revenue of $16.2M (up 40.7% from a year earlier), net income of $1.29M and diluted EPS of $0.05; over the last four quarters revenue was $67.1M and net income −$32.1M; for the fiscal year ended December 2025 revenue was $57.0M, down 6.4% on the year before.
SURG annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $57.0M, gross profit n/a, operating income −$34.1M, net income −$36.1M (margin -63.3%), EPS −$1.80
- Fiscal year ended Dec 2024: revenue $60.9M, gross profit n/a, operating income −$43.5M, net income −$45.7M (margin -75.1%), EPS −$2.39
- Fiscal year ended Dec 2023: revenue $137M, gross profit n/a, operating income $18.9M, net income $20.6M (margin 15.0%), EPS $1.38
- Fiscal year ended Dec 2022: revenue $122M, gross profit n/a, operating income $634K, net income −$681K (margin -0.6%), EPS −$0.05
- Fiscal year ended Dec 2021: revenue $51.1M, gross profit n/a, operating income −$5.99M, net income −$13.5M (margin -26.5%), EPS −$3.09
SURG quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $16.2M (up 40.7% year over year), net income $1.29M, EPS $0.05
- Quarter ended Mar 31, 2026: revenue $16.0M (up 51.1% year over year), net income −$12.1M, EPS −$0.51
- Quarter ended Dec 31, 2025 (from the annual report): revenue $16.2M (up 68.7% year over year), net income −$13.9M, EPS −$0.68
- Quarter ended Sep 30, 2025: revenue $18.7M (up 291.6% year over year), net income −$7.49M, EPS −$0.38
- Quarter ended Jun 30, 2025: revenue $11.5M (down 23.6% year over year), net income −$7.08M, EPS −$0.36
- Quarter ended Mar 31, 2025: revenue $10.6M (down 66.3% year over year), net income −$7.64M, EPS −$0.38
- Quarter ended Dec 31, 2024 (from the annual report): revenue $9.60M (down 70.3% year over year), net income −$19.8M, EPS −$1.07
- Quarter ended Sep 30, 2024: revenue $4.77M (down 86.0% year over year), net income −$14.3M, EPS −$0.73
- Quarter ended Jun 30, 2024: revenue $15.1M (down 58.0% year over year), net income −$12.9M, EPS −$0.66
- Quarter ended Mar 31, 2024: revenue $31.4M (down 9.6% year over year), net income $1.22M, EPS $0.07
- Quarter ended Dec 31, 2023 (from the annual report): revenue $32.3M (down 10.8% year over year), net income $3.02M, EPS $0.18
- Quarter ended Sep 30, 2023: revenue $34.2M (down 5.6% year over year), net income $7.08M, EPS $0.49
- Quarter ended Jun 30, 2023: revenue $35.9M (up 28.1% year over year), net income $5.97M, EPS $0.40
- Quarter ended Mar 31, 2023: revenue $34.8M (up 64.5% year over year), net income $4.55M, EPS $0.31
- Quarter ended Dec 31, 2022 (from the annual report): revenue $36.2M (up 155.9% year over year), net income $3.04M, EPS $0.25
- Quarter ended Sep 30, 2022: revenue $36.2M (up 148.8% year over year), net income −$1.54M, EPS −$0.12
- Quarter ended Jun 30, 2022: revenue $28.0M (up 146.1% year over year), net income −$973K, EPS −$0.08
- Quarter ended Mar 31, 2022: revenue $21.1M (up 92.4% year over year), net income −$1.21M, EPS −$0.10
- Quarter ended Dec 31, 2021 (from the annual report): revenue $14.2M, net income −$6.84M, EPS −$2.54
- Quarter ended Sep 30, 2021: revenue $14.5M, net income −$1.66M, EPS −$0.51
SURG cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$21.3M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$21.3M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow $10.3M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow $793K, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$15.3M, share buybacks n/a
SURG balance sheet
- Jun 30, 2026: cash $1.95M, total assets $9.24M, total liabilities $30.0M, shareholders' equity −$20.7M
- Mar 31, 2026: cash $1.99M, total assets $9.50M, total liabilities $33.4M, shareholders' equity −$23.8M
- Dec 31, 2025: cash $1.73M, total assets $8.52M, total liabilities $23.9M, shareholders' equity −$15.3M
- Sep 30, 2025: cash $2.51M, total assets $14.5M, total liabilities $20.9M, shareholders' equity −$6.37M
- Jun 30, 2025: cash $4.40M, total assets $15.2M, total liabilities $15.2M, shareholders' equity $116K
- Mar 31, 2025: cash $5.40M, total assets $15.7M, total liabilities $7.88M, shareholders' equity $7.84M
- Dec 31, 2024: cash $11.8M, total assets $24.0M, total liabilities $8.71M, shareholders' equity $15.3M
- Sep 30, 2024: cash $13.7M, total assets $41.5M, total liabilities $8.22M, shareholders' equity $33.2M
What is SURG's revenue?
SURGEPAYS INC reported $67.1M of revenue over its last four quarters, through June 30, 2026.
Is SURG profitable?
No. SURGEPAYS INC lost $32.1M over the last four quarters.
What is SURG's EPS?
Diluted earnings per share over the last four quarters were −$1.52; $0.05 in the latest quarter.